Segments in this Video

Kiran Mazumdar-Shaw: Profile (03:07)

FREE PREVIEW

Mazumdar-Shaw considers herself an accidental entrepreneur and is one of the most powerful women in India. "Biocon" is a leading pharmaceutical company that manufactures components for Bristol Myers Squib and Mylan. India needs large scale initiatives to bridge divides in inequity.

Susana Gimenez: Profile (03:18)

Gimenez hosts one of the highest-rated talk shows in Argentina, runs the magazine "Susana," and acts in movies. After her divorce, Gimenez becomes a model; she compares herself to Oprah Winfrey.

Future Plans (04:50)

Mazumdar-Shaw discusses her parents' encouragement to become an entrepreneur and her management style. Gimenez wants to act in Hollywood and hates to ask personal questions. Women need to be driven, take chances, and break out of the mold to be successful.

For additional digital leasing and purchase options contact a media consultant at 800-257-5126
(press option 3) or sales@films.com.

Kiran Mazumdar-Shaw/Susana Gimenez

Part of the Series : Leading Women: Series 1
DVD (Chaptered) Price: $129.95
DVD + 3-Year Streaming Price: $194.93
3-Year Streaming Price: $129.95

Share

Description

This month on Leading Women - a woman dubbed "the richest self-made woman in India" and one referred to as "the Oprah Winfrey of Argentina." At just 25, Kiran Mazumdar-Shaw took a degree in making beer and malt and figured out how to make pharmaceuticals and, in the process,  helped pioneer the biotech industry in India.  Today, her company, Biocon, is one of the country’s leading drug companies, valued at over $800 million. Becky Anderson reports on Shaw’s remarkable journey. Susana Gimenez has been a television mainstay in Argentina for over 25 years. CNN’s Felicia Taylor speaks with the savvy businesswoman who as has amassed a legion of fans over the course of a career that spans film, theater and magazine publishing.

Length: 12 minutes

Item#: BVL210539

ISBN: 978-1-63722-129-7

Copyright date: ©2012

Performance Rights

Prices include public performance rights.

Not available to Home Video and Publisher customers.


Share